A preclinical study of MK-2206 in epithelial morphology of pancreatic cancer cells by Wang et al. [72] showed that AKT phosphorylation is inhibited, and cell proliferation is attenuated by the application of the MK-2206 inhibitor. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.